Trexquant Investment LP Innoviva, Inc. Transaction History

Trexquant Investment LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$15.39 - $20.25 $249,810 - $328,698	-16,232 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $258,251 - $303,863	16,232 New	16,232 $280,000
Q4 2020 Feb 11, 2021	SELL	$9.33 - $12.48 $163,984 - $219,348	-17,576 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$10.33 - $14.49 $181,560 - $254,676	17,576 New	17,576 $184,000
Q3 2019 Nov 08, 2019	SELL	$10.05 - $14.55 $136,298 - $197,327	-13,562 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$13.1 - $14.95 $177,662 - $202,751	13,562 New	13,562 $197,000
Q1 2019 May 13, 2019	SELL	$13.69 - $20.06 $203,679 - $298,452	-14,878 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$13.96 - $18.26 $77,589 - $101,489	-5,558 Reduced 27.2%	14,878 $260,000
Q3 2018 Nov 09, 2018	SELL	$13.63 - $15.7 $46,587 - $53,662	-3,418 Reduced 14.33%	20,436 $311,000
Q2 2018 Aug 07, 2018	SELL	$13.44 - $17.59 $138,526 - $181,300	-10,307 Reduced 30.17%	23,854 $329,000
Q1 2018 May 03, 2018	BUY	$13.8 - $16.99 $471,421 - $580,395	34,161 New	34,161 $569,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.